Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

9.28
Delayed Data
As of 4:00pm ET
 +0.16 / +1.75%
Today’s Change
7.12
Today|||52-Week Range
11.85
-7.66%
Year-to-Date
Weekly CEO Buys
1:12pm / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close9.12
Today’s open9.10
Day’s range9.08 - 9.31
Volume2,236,769
Average volume (3 months)3,254,263
Market cap$5.0B
Dividend yield--
Data as of 4:00pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-30.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratio31.5
Price/Sales9.97
Price/Book2.51

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+0.28+0.23%
ENDPEndo International P...-0.21-1.00%
TAROTaro Pharmaceutical ...-1.66-1.29%
TSROTESARO Inc-0.58-0.67%
Data as of 4:02pm ET, 08/29/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts

Partner Offers

Search for Jobs